Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 702712100 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Lynx1 Capital Management LP
13D
|
21.0% |
7/2/2026
Event 6/25/2026
|
||
| Lynx1 Capital Management LP | 21.0% | |||
| Weston Nichols | 21.0% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (2) | ||||
| Erste Asset Management GmbH 13G/A | 4.4% |
11/14/2024
Event 3/31/2024
|
||
|
Orbimed Advisors LLC
13D/A
|
4.3% |
7/24/2025
Event 7/22/2025
|
||
| Orbimed Advisors LLC | 4.3% | |||
| Orbimed Capital GP VII LLC | 4.3% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2025 Q3 | 2 | 87.4 k | $702 k |
| 2025 Q2 | 42 | 35.1 M | $33.0 M |
| 2025 Q1 | 44 | 36.3 M | $12.8 M |
| 2024 Q4 | 48 | 37.6 M | $21.6 M |
| 2024 Q3 | 48 | 38.7 M | $27.1 M |
| 2024 Q2 | 50 | 40.3 M | $32.0 M |
| 2024 Q1 | 57 | 40.3 M | $54.4 M |
| 2023 Q4 | 58 | 32.8 M | $33.1 M |
| 2023 Q3 | 53 | 32.4 M | $21.3 M |
| 2023 Q2 | 58 | 33.4 M | $31.4 M |
| 2023 Q1 | 62 | 35.5 M | $34.0 M |
| 2022 Q4 | 71 | 37.5 M | $51.7 M |
| 2022 Q3 | 78 | 39.4 M | $49.3 M |
| 2022 Q2 | 89 | 42.2 M | $99.6 M |
| 2022 Q1 | 112 | 43.0 M | $133 M |
| 2021 Q4 | 107 | 43.7 M | $278 M |
| 2021 Q3 | 106 | 42.1 M | $419 M |
| 2021 Q2 | 104 | 44.6 M | $559 M |
| 2021 Q1 | 92 | 45.0 M | $786 M |
| 2020 Q4 | 72 | 32.0 M | $818 M |
| 2020 Q3 | 72 | 30.8 M | $403 M |
| 2020 Q2 | 67 | 31.6 M | $863 M |
| 2020 Q1 | 47 | 29.4 M | $462 M |